Clinical Evaluation of Khadirarishta and Kanchanara guggulu in the management of Uterine Fibroids-An Exploratory study - IMR-UF-TVM

Central Council for Research in Ayurvedic Sciences CCRAS0 个研究点目标入组 40 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Symptomatic Females, 25-50 yrs
•Uterine fibroids, uterine size < 12 weeks, and at least one fibroid >2 cm but none >5 cm on U/S
•Pre menopausal ladies with Uterine Fibroids getting at least 1 menstrual period in last three months.
•Normal PAP smear.

•Pregnancy, Lactation.
•Unexplained vaginal bleeding, cervical dysplasia, abnormal ovarian or adnexal mass.
•History of malignancy within the past 5 years.
•Use of estrogen or progesterone-containing compounds, such as oral contraceptives and hormone replacement therapy, within 8 weeks of study entry, including transdermal, injectable, vaginal and oral preparations.
•Use of herbal medication having estrogenic or antiestrogenic effect within the past 3 months.
•Known recent rapid growth of fibroids, defined as a doubling in size in six months.
•Haemoglobin level below 8gm%
•Patients suffering from any other major systemic illness necessitating long term drug Therapy

发起方

Central Council for Research in Ayurvedic Sciences CCRAS